Skip to content Skip to sidebar Skip to footer

Newsletter

Tech Stocks

Test text

Race Oncology Jumps 23% as Researchers Uncover Key Mechanism Behind Lead Cancer Drug

Race Oncology Soars 23% on Breakthrough Discovery Targeting MYC Race Oncology (ASX: RAC) opened strongly, rising 23 percent after releasing new insights into how its lead cancer drug, bisantrene (RC220 Bisantrene, RCDS1), actually works inside the body. The company’s researchers found that the drug attaches to and stabilises DNA and RNA structures known as…

ByCharlie YouldenOctober 2, 2025

Metallium (ASX: MTM) Surges 23% on Glencore Partnership: Full Investor Breakdown

Glencore Deal Sends Metallium (ASX: MTM) Shares Soaring 23% Metallium (ASX: MTM) has quickly become one of the most talked-about names on the ASX, with recent momentum driven by news that could reshape its path forward. The latest catalyst was a memorandum of understanding with a subsidiary of Glencore plc, one of the world’s largest…

ByCharlie YouldenOctober 2, 2025

DroneShield Surges 40% After Hitting 4,000 Units Sold and Securing AUD 7.9m in New Orders

Droneshield (ASX: DRO) has been one of the standout movers on the ASX in recent months, with the stock surging another 40 percent this week. For investors watching the defence technology space, this momentum reflects investor optimism on the back of the latest driver being a series of Department of Defence contracts that helped the…

ByCharlie YouldenOctober 1, 2025

The S&P/ASX All Technology Index: Here’s what investors need to know, and the 5 top stocks in it!

In the last 12 months, the S&P/ASX All Technology Index celebrated 6 years since inception and has netted a return of 27% vs the ASX 200's 7% gain as of September 24, 2025. We thought it was about time to write about this indice. Specifically how has it performed over time, the role it plays…

ByNick SundichSeptember 26, 2025

ECT (Environmental Clean Technologies) rockets 111%, but why?

ECT Shares Explode After Flash Joule Acquisition Environmental Clean Technologies (ASX:ECT) turned heads this morning, ripping more than 100 percent higher after unveiling a deal with Rice University that could redefine how we think about cleaning up “forever chemicals.” For years, investors have watched governments and corporations struggle with the rising costs of remediating PFAS…

ByCharlie YouldenSeptember 25, 2025

Will Dotz Nano Carbon Capture Edge Drive Its Share Price Higher?

Investors Eye Dotz Nano as Carbon Capture Stakes Reach New Highs Investors have started paying closer attention to Dotz Nano (ASX:DTZ), a company positioned at the intersection of advanced materials and climate technology. In a market where governments and corporations are racing to find scalable carbon capture solutions, Dotz has emerged with a product that…

ByCharlie YouldenSeptember 25, 2025

Nvidia Bets USD 100 Billion on OpenAI’s Next Leap

Can Nvidia’s USD 100 Billion AI Investment Deliver Sustainable Profits? Nvidia (NASDAQ: NVDA) has just taken its most ambitious step yet in the race to power artificial intelligence. In partnership with OpenAI, the chipmaker announced a USD 100 billion investment to build out massive data centers capable of delivering ten gigawatts of computing power. To…

ByCharlie YouldenSeptember 24, 2025

Is another boom in ASX BNPL stocks brewing? And how would Mk. 2 differ from Mk. 1

Is a new era on the horizon for ASX BNPL stocks? After a boom that lasted from Afterpay's May 2016 IPO to its acquisition in the September quarter of CY21, there was a crunch in the sector. Rising interest rates and inflation sent many companies - Openpay, Laybuy, Sezzle, Payright and Zebit just to name a…

ByNick SundichSeptember 23, 2025

Starpharma (ASX: SPL) Soars 70% on Genentech Deal

Starpharma Lands Genentech Collaboration Starpharma (ASX: SPL) has caught investor attention with a stunning 70 percent share price surge after unveiling a collaboration with global biotech giant Genentech. At the heart of the deal is Starpharma’s DEP platform, which uses dendrimers—tiny, tree-like molecules designed to carry cancer drugs more effectively through the body. By “loading”…

ByCharlie YouldenSeptember 22, 2025

Vection Technologies (ASX: VR1) Surges 30% – What Sparked the Rally and What Comes Next?

Vection Technologies Soars on A$22 Million NATO Defence Deal — A Turning Point or Just a Spark? Vection Technologies (ASX: VR1) has kicked off the week with a surge of more than 30 percent, fueled by news of a multi-year agreement with a NATO-approved partner in the European defence sector. The deal, worth around A$22…

ByCharlie YouldenSeptember 22, 2025

the Kick-ass Multipurpose WordPress Theme

Tech Stocks

Race Oncology Jumps 23% as Researchers Uncover Key Mechanism Behind Lead Cancer Drug

Metallium (ASX: MTM) Surges 23% on Glencore Partnership: Full Investor Breakdown

DroneShield Surges 40% After Hitting 4,000 Units Sold and Securing AUD 7.9m in New Orders

The S&P/ASX All Technology Index: Here’s what investors need to know, and the 5 top stocks in it!

ECT (Environmental Clean Technologies) rockets 111%, but why?

Will Dotz Nano Carbon Capture Edge Drive Its Share Price Higher?

Nvidia Bets USD 100 Billion on OpenAI’s Next Leap

Is another boom in ASX BNPL stocks brewing? And how would Mk. 2 differ from Mk. 1

Starpharma (ASX: SPL) Soars 70% on Genentech Deal

Vection Technologies (ASX: VR1) Surges 30% – What Sparked the Rally and What Comes Next?

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Tech Stocks

Stocks in Spotlight

Add Your Heading Text Here